Emphysema

SALBUMOL (Salbutamol)

SALBUMOL (Salbutamol)

Salbutamol is a selective β-2 adrenoceptor agonist. It has very little or no action on the β-1 receptors of the heart. At therapeutic doses, salbutamol acts on the β-2 receptors of the bronchial muscle, the end effect being dilation of the bronchial airways through relaxation of bronchial smooth muscle and reduction of airway resistance.

BROVANA® (arformoterol tartrate)

BROVANA® (arformoterol tartrate)

BROVANA Inhalation Solution is a long-acting beta2-adrenergic agonist ( beta2-agonist) indicated for the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema

ARCAPTA® NEOHALER®

ARCAPTA® NEOHALER® (indacaterol inhalation powder)

ARCAPTA NEOHALER is a long-acting beta2-adrenergic agonist indicated for: The long term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) defines COPD as a common, preventable, and treatable disease state characterized by persistent respiratory symptoms and airflow limitation due to airway and alveolar abnormalities

Gafacom